Topical β-adrenergic blocking agents are commonly used to treat glaucoma. Exacerbations
of asthma and bronchospasm caused by topical β-adrenergic ophthalmic preparations are …

Systemic effects from ocular medication are uncommon and may go undiagnosed. They
include cardiovascular, respiratory, and central nervous system effects of β-adrenoceptor …

Ophthalmic drugs. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe
PMC Menu About Tools Developers Help Contact us Helpdesk Feedback Twitter Blog Tech …

Local and systemic administration of certain drugs has resulted in many forms of visual
complications. These include blurred vision, disturbances in color vision, scotomata …

We undertook a non-concurrent prospective study of 191 Puerto Rican patients from August
1993 to April 1994. All patients had open angle glaucoma (OAG)(age ranged from 50 to 80 …

To evaluate the effects of two beta-adrenergic blocking agents on cardiopulmonary function,
we investigated two topical ophthalmologic preparations, betaxolol 1% and timolol 0.5%, in …

Numerous systemic drugs produce adverse effects that involve the eye. Pigmentary
inclusions of the lids or conjunctivae or both may be caused by a variety of drugs, including …

Abstract Information related to adverse drug effects caused by ocular medications and
ocular adverse effects of systemically administered drugs has increased over the last …

Medications used to treat glaucoma can have clinically important systemic effects in some
patients; these effects may not be recognized in elderly patients who have chronic medical …

Abstract Recent data concerning 1%, 2.5%, and 10% topical ocular phenylephrine, topical
ocular local anesthetics, carbonic anhydrase inhibitors, diazepam, liquid high-protein diets …